BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9070302)

  • 1. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
    Wu HK; Weksberg R; Minden MD; Squire JA
    Biochem Biophys Res Commun; 1997 Feb; 231(2):466-72. PubMed ID: 9070302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Loss of imprinting of insulin-like growth factor II gene in acute myeloid leukemia].
    Liu Y; Yang B; Zhu H; Wang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):39-41. PubMed ID: 10653908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
    Wu HK; Squire JA; Song Q; Weksberg R
    Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.
    Yun K; Fukumoto M; Jinno Y
    Am J Pathol; 1996 Apr; 148(4):1081-7. PubMed ID: 8644850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic imprinting of insulin-like growth factor-2 in infant leukemia and childhood neuroblastoma.
    Hattori H; Matsuzaki A; Suminoe A; Ihara K; Eguchi M; Tajiri T; Suita S; Ishii E; Hara T
    Cancer; 2000 May; 88(10):2372-7. PubMed ID: 10820361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
    Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
    Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
    Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
    J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of imprinting of IGF2 in Ewing's sarcoma.
    Zhan S; Shapiro DN; Helman LJ
    Oncogene; 1995 Dec; 11(12):2503-7. PubMed ID: 8545106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.
    Weksberg R; Shen DR; Fei YL; Song QL; Squire J
    Nat Genet; 1993 Oct; 5(2):143-50. PubMed ID: 8252039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.
    Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K
    Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR.
    Yun K; Soejima H; Merrie AE; McCall JL; Reeve AE
    J Pathol; 1999 Apr; 187(5):518-22. PubMed ID: 10398115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.
    Tessema M; Länger F; Bock O; Seltsam A; Metzig K; Hasemeier B; Kreipe H; Lehmann U
    Int J Oncol; 2005 Feb; 26(2):499-507. PubMed ID: 15645136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
    Vu TH; Hoffman AR
    Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby.
    Suzuki S; Renfree MB; Pask AJ; Shaw G; Kobayashi S; Kohda T; Kaneko-Ishino T; Ishino F
    Mech Dev; 2005 Feb; 122(2):213-22. PubMed ID: 15652708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
    Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
    Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues.
    Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB
    Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ; Grundy P; Polychronakos C
    Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57KIP2 and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue.
    Soejima H; McLay J; Hatada I; Mukai T; Jinno Y; Niikawa N; Yun K
    Lab Invest; 1998 Jan; 78(1):19-28. PubMed ID: 9461119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.